1 |
B. Tarr., T. Sambandan and S. Yalkowsky, A new parenteral emulsion for the administration of Taxol, Pharm. Res., 4, 162-165 (1987)
DOI
ScienceOn
|
2 |
P. Crosasso, M. Ceruti, P. Brusa, S. Arpicco, F. Dosio and L. Cartel, Preparation, characterization and properties of sterically stabilized paclitaxel-contaning liposomes, J. Controlled Rel., 63, 19-30 (2000)
DOI
ScienceOn
|
3 |
K. Westesen, H. Bunjes and M. H. J. Koch, Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential, J. Controlled. Rel., 48, 223-236 (1997)
DOI
ScienceOn
|
4 |
B. Sjostrom and B. Bergenstahl, Preparation of submicron drug particles in lecithin-stabilized O/W emulsions I. Model studies of the preparation of cholesteryl acetate, Int. J. Pharm., 88, 53-62 (1992)
DOI
ScienceOn
|
5 |
C. Schwarz, W. Mehnert, J. S. Lucks and R. H. Muller, Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization, J. Controlled Rel., 30, 83-96 (1994)
DOI
ScienceOn
|
6 |
T. Freytag, A. Dashevsky, L. Tillman, G.E. Hardee and R. Bodmeier, Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres, J. Controlled Rel., 69, 197-207 (2000)
DOI
ScienceOn
|
7 |
H. Alkan-Onyuksel, S. Ramakrishnan, H. Chai and J. Pezzuto, A mixed micellar formulation suitable for the parenteral administration of Taxol, Pharm. Res., 11, 206-212 (1994)
DOI
ScienceOn
|
8 |
R. Cavalli, O. Caputo and M. Gasco, Preparation and characterization of solid lipid nanospheres containing paclitaxel, Eur. J. Pharm. Sci., 10, 305-309 (2000)
DOI
ScienceOn
|
9 |
J. S. Lucks, R. H. Muller and B. Konig, Solid lipid nanoparticle (SLN)-an alternative parenteral drug carrier system, Eur. J. Pharm. Biopharm., 38, 33S (1992)
|
10 |
M. Garcia-Fuentes, D. Torres and M.J. Alonso, Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules, Colloid and Surfaces B: Biointerfaces, 27, 159-168 (2002)
|
11 |
A. Lamprecht, N. Uhrich, P.M. Hombreio, C.-M. Lehr, M. Hoffman and P. Maincent, Influences of process parameters on nanoparticle preparation performed by a double emission pressure homogenization technique, Int. J. Pharm., 196, 177-182 (2000)
DOI
ScienceOn
|
12 |
I. Hamrnikova, I. Miksik, M. Uhrova and Z. Deyl, Ultraviolet detector response of glycine and alanine homopeptide: Some specific features in capillary electrophoresis, Analy. Chim. Acta, 372, 257-272 (1998)
DOI
ScienceOn
|
13 |
F.Q. Hu, Y. Hong and H. Yuan, Preparation and characterization of solid lipid nanoparticles containing peptide, Int. J. Pharm., 273, 29-35 (2004)
DOI
ScienceOn
|
14 |
C. Witschi and E. Doelker, Influence of the microencapsulation method and peptide loading on poly (lactic acid) and poly (lactic-co-glycolic acid) degradation during in vitro testing, Int. J. Pharm., 51, 327-341 (1998)
|
15 |
C. Freitas and R.H. Muller, Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions, Int. J. Pharm., 168, 221-229 (1998)
DOI
ScienceOn
|
16 |
J. Herrmarin and R. Bodmeier, Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on W/O/W-multiple emulsions, Int. J. Pharm., 126, 129-138 (1995)
DOI
ScienceOn
|
17 |
L. Mu and S. Feng, Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spay drying technique with lipid/cholesterol emulsifiers, J. Controlled Rel., 76, 239-254 (2001)
DOI
ScienceOn
|
18 |
R. H. Muller, A. Lippacher and S. Gohla, Solid Lipid Nanoparticles (SLN) as a Carrier System for the Controlled Release of Drugs, Handbook of Pharmaceutical Controlled Release Technology, Chapter 19, 377-391 (2000)
|
19 |
U. Sharma, S. Balasubramanian and R. Straubinger, Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins, J . Pharm. Sci., 84, 1223-1230 (1995)
DOI
ScienceOn
|